MedTrace Logo

Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer

NCT00003086 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-07-14

No results posted yet for this study

Summary

RATIONALE: Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.

PURPOSE: Phase I/II trial to study the effectiveness of repeated use of high-dose chemotherapy plus bone marrow transplantation and samarium 153 in treating women who have stage IV breast cancer.

Conditions

Interventions

BIOLOGICAL

filgrastim

DRUG

CAF regimen

DRUG

carboplatin

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

fluorouracil

DRUG

ifosfamide

DRUG

melphalan

DRUG

paclitaxel

DRUG

thiotepa

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

samarium Sm 153 lexidronam pentasodium

Sponsors & Collaborators

  • Louisiana State University Health Sciences Center Shreveport

    lead OTHER

Principal Investigators

  • Benjamin B. Weinberger, MD · Feist-Weiller Cancer Center at Louisiana State University Health Sciences

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-03-31
Primary Completion
2001-01-28
Completion
2001-01-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003086 on ClinicalTrials.gov